This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Uchicago Argonne, LLC. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Innovations by Harry C Fry
Introduction
Harry C Fry is an accomplished inventor based in Lincolnwood, IL (US). He has made significant contributions to the field of nanobiomedicine, focusing on anti-inflammatory agents and cancer treatment technologies. With a total of 2 patents, Fry's work demonstrates a commitment to advancing medical science through innovative solutions.
Latest Patents
Fry's latest patents include "Heme peptide materials for anti-inflammatory regenerative nanobiomedicine" and "Metal oxide nanoparticle for cell lysis." The first patent addresses the toxicity and inflammatory response triggered by heme released from sustained injury. It introduces a class of peptide amphiphiles that mimic the function of heme oxygenase, which can bind and break down heme. This innovation has potential applications in promoting tissue repair and wound healing. The second patent involves a nanostructure that utilizes metal oxide nanoparticles (MOX NPs) coupled with a cancer recognition molecule and a biocatalyst. This technology selectively targets cancer cells, generating reactive oxygen species (ROS) that can lyse or induce apoptosis in the cancer cells.
Career Highlights
Fry is currently associated with UChicago Argonne, LLC, where he continues to develop groundbreaking technologies. His work has garnered attention for its potential to revolutionize treatment methods in regenerative medicine and oncology.
Collaborations
Fry collaborates with notable colleagues, including Elena A Rozhkova and Nada M Dimitrijevic, who contribute to his research endeavors.
Conclusion
Harry C Fry's innovative patents and research in nanobiomedicine highlight his dedication to improving health outcomes through scientific advancements. His contributions are paving the way for future developments in medical technology.